|
The Immunohistochemistry Antibody Company
|
|
|
General Cancer Screen 155 Tissue Microarray - LS-SCA155This tissue microarray is available for use in LSBio Immunohistochemistry Studies only. |
| Catalog ID: | LS-SCA155 |
| Product Name: | General Cancer Screen 155 |
| Description: | Various organs oral cavity disease |
| Format: | FFPE |
| Category: | Human Multi-Tumor |
| QA/QC: | H&E reviewed; IHC validated with a positive control antibody |
| Storage: | Short term RT; Long term 4ºC |
| Clinical History: | No |
| Tissue Marker: | No |
| Stage/Grade: | Yes |
| Core Diameter: | 2 mm |
| Core Thickness: | 5 µm |
| Cases: | 47 |
| Cores: | 48 |
| Slides Per Set: | 1 |
LS-SCA155 Tissue Microarray Map
Slide Number 1
| LABEL |
|
Diagnosis Type Legend
| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
Element Tissue Legend
Parotid gland (Pdg); Salivary gland, Submandibular (Sal); Tongue (Tng); Tongue, Fibrous and epithelial tissue (Tng); Tongue, Thyroglossal duct (Tng);
LS-SCA155 Element Details
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type | Tumor Grade | Tumor Differentiation |
|---|---|---|---|---|---|---|---|---|---|
| 1 | A1 | Human | M | 36 y | Tongue (Tng) | Squamous cell carcinoma | Malignant | Grade I | |
| 1 | A2 | Human | M | 45 y | Tongue (Tng) | Epithelial-myoepithelial carcinoma | Malignant | ||
| 1 | A3 | Human | M | 66 y | Tongue (Tng) | Mucoepidermoid carcinoma | Malignant | Grade III | |
| 1 | A4 | Human | F | 52 y | Tongue (Tng) | Acinic cell carcinoma | Malignant | ||
| 1 | A5 | Human | M | 47 y | Tongue (Tng) | Infiltrating pleomorphic adenoma | Tumor | ||
| 1 | A6 | Human | F | 51 y | Tongue (Tng) | Squamous cell carcinoma | Malignant | Grade I | |
| 1 | A7 | Human | M | 81 y | Tongue (Tng) | Squamous cell carcinoma | Malignant | Grade II | |
| 1 | A8 | Human | M | 60 y | Tongue (Tng) | Squamous cell carcinoma | Malignant | Grade I | |
| 1 | B1 | Human | M | 55 y | Tongue (Tng) | Squamous cell carcinoma | Malignant | Grade II | |
| 1 | B2 | Human | M | 63 y | Tongue (Tng) | Squamous cell carcinoma | Malignant | Grade II | |
| 1 | B3 | Human | F | 70 y | Parotid gland (Pdg) | Adenocarcinoma, Mucinous | Malignant | ||
| 1 | B4 | Human | M | 64 y | Parotid gland (Pdg) | Epithelial-myoepithelial carcinoma | Malignant | ||
| 1 | B5 | Human | F | 50 y | Tongue (Tng) | Adenocarcinoma, Undifferentiated | Malignant | Undifferentiated | |
| 1 | B6 | Human | M | 79 y | Tongue (Tng) | Squamous cell carcinoma | Malignant | Grade I | |
| 1 | B7 | Human | M | 57 y | Tongue (Tng) | Squamous cell carcinoma | Malignant | Grade II | |
| 1 | B8 | Human | M | 53 y | Tongue (Tng) | Squamous cell carcinoma | Malignant | Grade I | |
| 1 | C1 | Human | M | 61 y | Tongue (Tng) | Adenocarcinoma | Malignant | Grade III | |
| 1 | C2 | Human | M | 37 y | Tongue (Tng) | Adenoid cystic carcinoma | Malignant | ||
| 1 | C3 | Human | M | 31 y | Parotid gland (Pdg) | Squamous cell carcinoma | Malignant | Grade II | |
| 1 | C4 | Human | F | 78 y | Tongue (Tng) | Malignant fibrous histiocytoma | Malignant | ||
| 1 | C5 | Human | F | 72 y | Tongue (Tng) | Mucoepidermoid carcinoma | Malignant | Grade III | |
| 1 | C6 | Human | F | 52 y | Tongue (Tng) | Adenosquamous carcinoma | Malignant | ||
| 1 | C7 | Human | F | 52 y | Tongue (Tng) | Squamous cell carcinoma | Malignant | Grade III | |
| 1 | C8 | Human | F | 45 y | Tongue (Tng) | Squamous cell carcinoma | Malignant | Grade III | |
| 1 | D1 | Human | F | 50 y | Tongue (Tng) | Squamous cell carcinoma | Malignant | Grade II | |
| 1 | D2 | Human | M | 17 y | Tongue (Tng) | Adenoma, Pleomorphic | Tumor | ||
| 1 | D3 | Human | M | 63 y | Parotid gland (Pdg) | Adenocarcinoma | Malignant | Grade II | |
| 1 | D4 | Human | M | 49 y | Parotid gland (Pdg) | Adenolymphoma | Malignant | ||
| 1 | D5 | Human | F | 52 y | Tongue (Tng) | Malignant myoepithelioma | Malignant | ||
| 1 | D6 | Human | M | 66 y | Tongue (Tng) | Adenoid cystic carcinoma | Malignant | ||
| 1 | D7 | Human | M | 63 y | Tongue (Tng) | Squamous cell carcinoma | Malignant | Grade I | |
| 1 | D8 | Human | F | 56 y | Tongue (Tng) | Squamous cell carcinoma | Malignant | Grade III | |
| 1 | E1 | Human | M | 20 y | Tongue, Fibrous and epithelial tissue (Tng) | Hyperplasia | Diseased | ||
| 1 | E2 | Human | M | 49 y | Tongue (Tng) | Squamous cell carcinoma | Malignant | Grade I | |
| 1 | E3 | Human | F | 70 y | Tongue (Tng) | Basal cell adenocarcinoma | Malignant | ||
| 1 | E4 | Human | F | 80 y | Parotid gland (Pdg) | Carcinoma | Malignant | Undifferentiated | |
| 1 | E5 | Human | F | 53 y | Parotid gland (Pdg) | Myoepithelioma | Tumor | ||
| 1 | E6 | Human | M | 49 y | Tongue (Tng) | Squamous cell carcinoma | Malignant | Grade II | |
| 1 | E7 | Human | F | 79 y | Tongue (Tng) | Basal cell adenocarcinoma | Malignant | ||
| 1 | E8 | Human | M | 54 y | Tongue (Tng) | Squamous cell carcinoma | Malignant | Grade III | |
| 1 | F1 | Human | F | 23 y | Salivary gland, Submandibular (Sal) | Inflammation | Inflammatory | ||
| 1 | F2 | Human | M | 63 y | Tongue (Tng) | Sarcomatoid carcinoma | Malignant | ||
| 1 | F3 | Human | F | 55 y | Parotid gland (Pdg) | Adenocarcinoma, Mucinous | Malignant | Grade III | |
| 1 | F4 | Human | M | 37 y | Tongue (Tng) | Acidophil lymphogranuloma | Tumor | ||
| 1 | F5 | Human | F | 28 y | Tongue (Tng) | Lymphoepithelioid lymphoma | Malignant | ||
| 1 | F6 | Human | F | 50 y | Tongue (Tng) | Adenocarcinoma infiltrating skeletal muscle | Malignant | ||
| 1 | F7 | Human | M | 57 y | Tongue (Tng) | Mucoepidermoid carcinoma | Malignant | Grade II | |
| 1 | F8 | Human | M | 21 y | Tongue, Thyroglossal duct (Tng) | Cyst | Benign non-neoplastic |